Efficacy of Ultrasound-Guided Percutaneous Electrolysis for Hip Pain in Male Ice Hockey Players

May 29, 2026 updated by: Veronique Vidal

Efficacy of Percutaneous Electrolysis Treatment for Hip Pain in Male Ice Hockey Players: a Pilot Study

Groin pain is a common and limiting condition in ice hockey players, often related to the high mechanical demands placed on the hip during skating. Repetitive movements involving hip flexion, abduction, and rotation may contribute to functional impairment and persistent symptoms.

Recent clinical interest has focused on the relationship between the iliopsoas muscle and the anterior hip capsule, as their close anatomical and functional interaction may play a role in the development of hip-related groin pain.

Percutaneous needle electrolysis (PNE) is a minimally invasive, ultrasound-guided technique used to promote tissue remodeling and pain reduction in musculoskeletal conditions. However, its application to the anterior hip capsule has not yet been investigated.

This pilot experimental study aims to evaluate the effects of three sessions of PNE applied to the anterior hip capsule in male ice hockey players with groin pain. The main hypothesis is that this intervention may improve hip function by reducing pain and enhancing mobility and muscle strength.

Outcomes include hip flexor strength, hip flexion range of motion, FADIR test results, and patient-reported outcomes measured with the HAGOS questionnaire. Assessments will be performed before and after the intervention, as well as at a 4-week follow-up.

Study Overview

Detailed Description

Groin pain represents one of the most frequent and challenging musculoskeletal conditions in athletes, particularly in sports characterized by high mechanical demands on the hip joint, such as ice hockey. The skating motion involves repetitive cycles of hip flexion, abduction, and rotation performed at high intensity, exposing the hip joint and surrounding soft tissues to substantial mechanical stress. These repetitive loads are considered a key contributing factor in the development of chronic symptoms, functional limitations, and performance impairment.

From a clinical and biomechanical perspective, increasing attention has been directed toward the relationship between the iliopsoas muscle and the anterior capsule of the hip joint. Due to their close anatomical proximity and continuous interaction during dynamic activities, these structures are subjected to repetitive frictional and tensile forces. This mechanical interaction may contribute to the development of adaptive changes in the periarticular tissues, potentially leading to reduced mobility, altered neuromuscular control, and persistent pain in the anterior hip or groin region.

The complexity of groin pain in athletes has been highlighted in international consensus statements, which describe it as a multifactorial condition involving different anatomical structures and clinical entities. Within this framework, hip-related groin pain and iliopsoas-related pain are recognized as relevant components, reinforcing the importance of investigating periarticular hip structures, including the anterior capsule.

Percutaneous needle electrolysis (PNE), also referred to as musculoskeletal percutaneous electrolysis (EPM), is a minimally invasive intervention performed under ultrasound guidance. The technique involves the application of a controlled galvanic current through a fine needle inserted into the target tissue. This intervention is thought to induce a localized electrochemical response that promotes tissue remodeling, modulates the inflammatory process, and facilitates the regeneration of altered or dysfunctional soft tissues.

The clinical use of PNE has been widely described in the treatment of chronic musculoskeletal conditions characterized by degenerative or fibrotic tissue changes, such as tendinopathies. Experimental evidence also suggests that this technique may have beneficial effects in fibrotic environments by promoting structural reorganization and improving tissue function. However, despite these promising findings, there is currently no available literature specifically investigating the effects of PNE applied to the anterior capsule of the hip joint.

In this context, the present study is designed as a pilot experimental trial aimed at exploring the potential clinical effects of PNE when applied to the anterior hip capsule in male ice hockey players presenting with groin pain. The exploratory nature of this study is intended to generate preliminary data and to assess the feasibility and potential clinical relevance of this intervention in a population exposed to high biomechanical demands.

The working hypothesis is that targeted application of PNE at the level of the anterior hip capsule may contribute to improvements in hip function by reducing pain, enhancing joint mobility, and improving muscle performance.

To evaluate these effects, a set of objective, clinical, and patient-reported outcomes will be collected at baseline, immediately after the intervention period, and at a short-term follow-up. Objective measures will focus on hip flexor muscle strength and passive hip flexion range of motion, while clinical assessment will include the FADIR test as a provocation test for hip-related symptoms. Subjective outcomes will be assessed using the Hip and Groin Outcome Score (HAGOS), a validated questionnaire covering symptoms, pain, daily activities, sports participation, and quality of life.

The results of this pilot study are expected to provide initial insights into the potential role of PNE in the management of hip-related groin pain and to support the development of future controlled and randomized studies with larger sample sizes.

Study Type

Interventional

Enrollment (Estimated)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Canton Ticino
      • Ambrì, Canton Ticino, Switzerland, 6775
        • Recruiting
        • Gottardo Arena
        • Contact:
        • Principal Investigator:
          • Veronique Vidal, Physiotherapist

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male ice hockey players (under-21 team)
  • Age between 18 and 21 years
  • Presence of groin pain or anterior hip pain
  • Positive FADIR test
  • Ability to participate in regular training activities
  • Willingness to participate and provide informed consent

Exclusion Criteria:

  • Presence of concomitant orthopedic or systemic conditions.
  • Belonephobia (fear of needles).
  • Contraindications to invasive physiotherapy techniques (e.g., infection, skin lesions at the treatment site, bleeding disorders, Allergies to metals.)
  • Use of other concurrent treatments targeting the hip during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Percutaneous electrolysis intervention
Participants will receive three sessions of ultrasound-guided musculoskeletal percutaneous electrolysis applied to the anterior capsule of the hip.

The intervention consists of the application of ultrasound-guided musculoskeletal percutaneous electrolysis (PNE) to the anterior capsule of the hip. Under aseptic conditions, including skin disinfection, use of sterile gloves, and a disposable ultrasound probe cover, a single-use needle is inserted under real-time ultrasound guidance toward the anterior hip capsule.

The needle is introduced with an oblique approach (approximately 45° relative to the skin) until reaching the target tissue. Once positioned, a controlled galvanic current is applied through the needle to induce a localized electrochemical response aimed at promoting tissue remodeling.

Each participant will receive a total of three treatment sessions. The procedure is performed by a qualified clinician experienced in ultrasound-guided invasive physiotherapy techniques.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip and groin symptoms measured with HAGOS questionnaire
Time Frame: Baseline (pre-intervention), 2-3 days post-intervention, and 4-week follow-up
Patient-reported outcomes will be assessed using the Hip and Groin Outcome Score (HAGOS), a validated questionnaire composed of six subscales: Symptoms, Pain, Activities of Daily Living, Sport and Recreation, Participation in Physical Activities, and Quality of Life. Scores range from 0 to 100, with higher scores indicating better function and fewer symptoms.
Baseline (pre-intervention), 2-3 days post-intervention, and 4-week follow-up
Hip flexor strength measured with K-Force dynamometer
Time Frame: Baseline (pre-intervention), immediately post-intervention (after 3 sessions), and 4-week follow-up
Isometric maximum strength of the hip flexor muscles will be assessed using a K-Force dynamometer stabilized on a fixed support. Participants will perform maximal voluntary contractions in a standardized supine position with hip and knee flexed at 90°. Three trials will be performed, and the highest value will be recorded in kilograms (kg).
Baseline (pre-intervention), immediately post-intervention (after 3 sessions), and 4-week follow-up
Hip flexion range of motion measured with K-Move device
Time Frame: Baseline (pre-intervention), immediately post-intervention, and 4-week follow-up
Passive hip flexion range of motion will be measured in degrees using a K-Move motion sensor positioned on the anterior thigh. The participant will be assessed in a supine position, and the examiner will move the limb passively until the first resistance is perceived. Three measurements will be performed, and the highest value will be recorded.
Baseline (pre-intervention), immediately post-intervention, and 4-week follow-up
FADIR test outcome (positive/negative)
Time Frame: Baseline (pre-intervention), immediately post-intervention, and 4-week follow-up
The FADIR (flexion, adduction, internal rotation) test will be performed as a clinical provocation test to assess hip-related groin pain. The test will be considered positive if it reproduces the participant's typical anterior or groin pain. Results will be recorded as a dichotomous outcome (positive/negative).
Baseline (pre-intervention), immediately post-intervention, and 4-week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Veronique Vidal, Physiotherapist

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 29, 2026

Primary Completion (Estimated)

July 17, 2026

Study Completion (Estimated)

August 14, 2026

Study Registration Dates

First Submitted

April 8, 2026

First Submitted That Met QC Criteria

April 8, 2026

First Posted (Actual)

April 14, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 29, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Groin Pain

Clinical Trials on Ultrasound-guided musculoskeletal percutaneous electrolysis

Subscribe